---MaaT Pharma renforce son équipe de direction en ajoutant une expertise en termes de développement…
MaaT PharmaMay 28, 2020
In response to the recent “FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation…
MaaT PharmaMarch 13, 2020
Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
nboutaouiJanuary 31, 2020
Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
MaaT PharmaJanuary 31, 2020
Lyon, France, November 6, 2019 – MaaT Pharma announced today that a poster will…
nboutaouiNovember 6, 2019
Jean-Marc Renard, MS, MBA, joins as Chief Business Officer Emmanuel Prestat, PhD, joins as Computational…
nboutaouiSeptember 10, 2019
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
nboutaouiAugust 13, 2019
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
nboutaouiJune 24, 2019
- First patents to cover the fundamental processes for accessing the human gut microbiome as…
nboutaouiMay 21, 2019
